Eagle Asset Management Inc Ptc Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$37.95 - $49.37 $16.5 Million - $21.4 Million	-433,834 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $2.81 Million - $4.13 Million	59,959 Added 16.04%	433,834 $21.3 Million
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $3.4 Million - $4.8 Million	-70,903 Reduced 15.94%	373,875 $25.2 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $492,380 - $618,810	10,843 Added 2.5%	444,778 $21 Million
Q2 2020 Aug 12, 2020	BUY	$42.56 - $54.98 $9.93 Million - $12.8 Million	233,212 Added 116.19%	433,935 $22 Million
Q1 2020 May 11, 2020	BUY	$32.37 - $59.36 $3.68 Million - $6.75 Million	113,712 Added 130.69%	200,723 $8.95 Million
Q4 2019 Feb 07, 2020	BUY	$32.22 - $50.07 $2.8 Million - $4.36 Million	87,011 New	87,011 $4.18 Million

232

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.